0
0
Read Time:11 Second
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 25, 2025, titled “Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %